Antibody-mediated immune enhancement in coxsackievirus B3 myocarditis

Journal of Molecular and Cellular Cardiology

Volumn 34, Issue 9, 2002, Pages 1227-1238

  Kishimoto, Chiharu ^a   Kurokawa, Masahiko ^a   Ochiai, Hiroshi ^a  

^a TOYAMA MEDICAL AND PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

Antibody mediated damage; Coxsackievirus B3; Fc receptors; Immune enhancement; Macrophages; Myocarditis

Indexed keywords

FC RECEPTOR; MACROPHAGE INFLAMMATORY PROTEIN 2;

ANIMAL CELL; ANTIBODY DEPENDENT LYMPHOCYTOTOXICITY; ARTICLE; COXSACKIE VIRUS; DISEASE SEVERITY; IMMUNE RESPONSE; INTERNALIZATION; MACROPHAGE ACTIVATION; MOUSE; NONHUMAN; PATHOGENESIS; PERSISTENT VIRUS INFECTION; PRIORITY JOURNAL; VIRUS MYOCARDITIS; VIRUS NEUTRALIZATION; VIRUS REPLICATION;

COXSACKIEVIRUS; MURINAE;

EID: 0036750848     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-2828(02)92087-0     Document Type: Article

References (35)

1. Mogensen SC. Role of macrophages in natural resistance to virus infections. Microbiol Rev 1979; 43: 1-26.
2. Halstead SB. Immune enhancement of viral infection. Prog Allergy 1982; 31: 301-364.
3. Halstead SB. Pathogenesis of dengue. Challenges to molecular biology. Science 1988: 239: 476-481.
4. Ochiai H, Kurokawa M, Hayashi K, Niwayama S. Antibody-mediated growth of influenza A NWS virus in macrophagelike cell line P388D1. J Virol 1988: 62: 20-26.
5. Richardson P, Mckenna W, Bristrow M, Maisch B, Mautner B, O'Connell J, Olsen E, Thiene G, Goodwin J, Gyarfas I, Martin I, Nordet P. Report of the World Health Organization/International Society of Federation of Cardiology. Task Force on the Definition and Classification of Cardiomyopathies. Circulation 1996; 93: 841-842.
6. Luppi P, Rudert WA, Zanone MM, Stassi G, Trucco G, Finegold D, Boyle GJ, Nido PD, McGowan FX, Trucco M. Idiopathic dilated cardiomyopathy. A superantigen-driven autoimmune disease. Circulation 1998; 98: 777-785.
7. Huber SA, Gauntt CJ, Sakkinen P. Enteroviruses and myocarditis. Viral pathogenesis through replication, cytokine induction, and immunopathogenicity. Adv Virus Res 1998; 51: 35-80.
8. Knowlton KV, Badorff C. The immune system in viral myocarditis. Maintaining the balance. Circ Res 1999; 85: 559-561.
9. Fujioka S, Kitaura Y, Ukimura A, Deguchi H, Kawamura K, Isomura T, Suma H, Shimizu A. Evaluation of viral infection in the myocardium of patients with idiopathic dilated cardiomyoopathy. J Am Coll Cardiol 2000; 36: 1920-1926.
10. Klingel K, Hohendal C, Canu A, Albrecht M, Seeman M, Mall G, Kandolf R. Ongoing enterovirus induced myocarditis in associated with persistent heart muscle infection: Quantitative analysis of virus replication, tissue damage, and inflammation. Proc Natl Acad Sci USA 1992; 89: 314-318.
11. Jin O, Sole MJ, Butany JW, Chia WK, McLanghlin PR, Liu P, Liew CC. Detection of enterovirus RNA in myocardialbiopsies from patients with myocarditis and cardiomyopathies using geneamplification by polymerase chain reaction. Circulation 1990; 82: 8-16.
12. Pauschinger M, Bowles NE, Fuentes-Garcia FJ, Pham V, Kuhl U, Schwimmbeck PL, Schultheiss HP, Towbin JA. Detection of adenoviral genome in the myocardium of adult patients with idiopathic left ventricular dysfunction. Circulation 1997: 99: 1348-1354.
13. Matteucci D. Paglianti M, Giangregori AM, Capobianchi MR, Dianzani F, Bendinelli M. Group B coxsackievirus readily establish persistent infections in human lymphoid cell lines. J Virol 1985: 56: 651-656.
14. Koren HS. Handwerger BS. Wunderlich JR. Identification of macrophage-like characteristics in a cultured murine tumor line. J Immunol 1975: 114: 894-897.
15. Kishimoto C. Kurokawa M, Ochiai H, Takada H. Hiraoka Y, Sasayama S, Shiraki K. Analysis of the pathogenesis of the coxsackievirus B3 myocarditis: Comparison of myocarditic and amyocarditic coxsackievirus B3 strains. In: Nagano M, Takada N, Dhalla NS (eds) The Cardio-Myopathic Heart 1993. New York: Raven Press.
16. Kishimoto C, Hiraoka Y, Takada H. T cell-mediated immune response enhances the severity of myocarditis in secondary cardiotropic virus infection in mice. Basic Res Cardiol 2001; 96: 439-445.
17. Kishimoto C, Shioji K. Active myocarditis is transferable in severe combined immunodeficient mice by antigen-sensitized T cells. Circulation 2001: 104: Suppl-II-684 (Abstract).
18. Beck MA, Shi Q, Morris VC, Levander OA. Rapid genomic evolution of a non-virulent coxsackievirus B3 in selenium deficient mice results in selection of a identical virulent isolates. Nature Med 1995; 1: 433-436.
19. Gauntt JC, Trousdale MD, Labadie DRL, Paque RE, Nelson T. Properties of coxsackievirus B3 variants which are amyocarditic or myocarditic for mice. J Med Virol 1979: 3: 207-220.
20. Kishimoto C. Kuroki Y. Hiraoka Y, Ochiai H, Kurokawa M, Sasayama S. Cytokine and murine coxsackievirus B3. Interleukin-2 suppressed myocarditis in the acute stage but enhanced the condition in the subsegment stage. Circulation 1994; 89: 2836-2842.
21. Kishimoto C. Abelmann WH. In vivo significance of T cells in the development of coxsackievirus B3 myocarditis in mice. Immature but antigen-specific T cells aggravate cardiac injury. Circ Res 1990; 67: 589-598.
22. Feng L, Xia Y. Yoshimura T, Wilson CB. Modulation of neutrophil influx in glomerulonephritis in the rat with anti-macrophage inflammatory protein-2 (MIP-2) antibody. J Clin Invest 1995; 95: 1009-1017.
23. Ochiai H, Sakai S. Kogure T, Hirabayashi T. Nakajima K, Terasawa K. Development and some applications of enzyme linked immnosorbent assay system for murine macrophage inflammatory protein-2 (MIP-2). Mediator Inflam 1996; 5: 206-209.
24. Scott DW, Gershon RK. Determination of total and mercaptoethanol-resistant antibody in the same serum sample. Clin Exp Immunol 1970; 6: 313-316.
25. 1. J Immunol 1999; 163: 6123-6131.
26. Gomez-Guerrero C, Duque N, Casado MT, Pastor C, Blanco J. Administration of IgG Fc fragments prevents glomerular injury in experimental immune complex nephritis. J Immunol 2000; 164: 2092-2101.
27. Takeda A, Tuazon CU, Ennis FA. Antibody-enhanced infection by HIV-1 via Fc receptor-mediated entry. Science 1988: 242: 580-583.
28. Obeysedere I, Hermon Y. Myocarditis and cardiomyopathy after arbovirus infection (dengue and chikungunya fever). Br Heart J 1972; 34: 821-827.
29. Anderson DW, Virmani R, Reilly J, O'Leary T, Cunnion RE, Robinowitz M, Macher AM, Punja U, Villaflor ST, Parrillo TE, Roberts W. Prevalent myocarditis at necropsy in the acquired immunodeficiency syndrome. J Am Coll Cardiol 1988: 11: 792-799.
30. Kurane I. Innis BL, Nimmannitya S, Nisalaka A, Meager A, Jenus J, Ennis FA. Activation oft lymphocytes in dengue virus infections. High levels of soluble interleukin 2 receptor, soluble CD4, soluble CD8, interleukin2 and interferon-γ in sera of children with dengue. J Clin Invest 1991; 88: 1473-1480.
31. Heim A. Zeuke S, Weiss S, Ruxdhewski W, Grumbach IM. Transient induction of cytokine production in human myocardial fibroblasts by coxsackievirus B3. Circ Res 2000; 86: 753-759.
32. Opavsky MA, Penninge J, Aitken K, Wen WH, Dawood F, Mak T, Liu P. Susceptibility to myocarditis is dependent on the response of αβ T lymphocytes to coxsackieviral infection. Circ Res 1999: 85: 551-558.
33. Hood LE. Weismann IL. Wood WB, Wilson JH. Immunology, 2nd edn 1983. Menlo Park, CA: The Benjamin-Cummings Publishing Co, 515.
34. Schulthesis HP, Ulrich G, Janda I. Melzner B. Ulrich G, Morad M. Antibody-mediated enhancement of calcium permeability in cardiac myocyte. J Exp Med 1988: 168: 2105-2119.
35. Kuan AP, Zuckie L, Liao L, Factor SM, Diamond B. Immunoglobulin isotype determines pathogenicity in antibody-mediated myocarditis in naïve mice. Circ Res 2000: 86: 281-285.